Multiple Myeloma

Latest News

Recap: MRD Negativity, Frailty, and Emerging Therapies in Multiple Myeloma
Recap: MRD Negativity, Frailty, and Emerging Therapies in Multiple Myeloma

March 24th 2023

An expert panel highlights novel therapeutic approaches for newly diagnosed and relapsed multiple myeloma.

A panel of experts reviews how the recent approval of teclistamab, a bispecific antibody, has changed the treatment landscape for patients with multiple myeloma.
Bispecific Antibodies Promise to be ‘Transformative’ in Multiple Myeloma

March 17th 2023

Recap: Mayo and Moffitt Face-Off in Myeloma Data Presentation
Recap: Mayo and Moffitt Face-Off in Myeloma Data Presentation

February 24th 2023

The FDA and European Medicines Agency accept applications for elranatamab for relapsed or refractory multiple myeloma.
FDA Grants Priority Review to Elranatamab for R/R Multiple Myeloma

February 22nd 2023

The investigational CAR T-cell therapy equecabtagene autoleucel receives fast track and regenerative medicine advanced therapy designations for managing relapsed or refractory multiple myeloma.
FDA Grants Fast Track and RMAT Designations to CAR T Product for R/R Myeloma

February 15th 2023

More News